UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of
Report (Date of earliest event reported): May 8, 2007
BIOANALYTICAL
SYSTEMS, INC.
|
(Exact
name of registrant as specified in its
charter)
|
Indiana
|
|
0-23357
|
|
35-1345024
|
(State
or other jurisdiction of incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification No.)
|
2701
KENT AVENUE
WEST
LAFAYETTE, INDIANA
|
|
47906-1382
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (765) 463-4527
The
information provided in Item 2.02 and Item 9.01 of this Form 8-K is being
furnished and shall not be deemed "filed" for the purpose of Section 18 of
the
Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that Section. The information in Item 2.02 and Item 9.01 of
this
Form 8-K shall not be incorporated by reference into any registration statement
or other document pursuant to the Securities Act of 1933, as
amended.
Item
2.02. Results
of Operations and Financial Condition.
On
May 8,
2007, Bioanalytical Systems, Inc. issued a press release announcing results
for
the second quarter of fiscal year 2007. The full text of the press release
is
furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by
reference.
Item
9.01. Financial
Statements and Exhibits.
|
99.1
|
Bioanalytical
Systems, Inc. press release, issued May 8,
2007.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
Bioanalytical
Systems, Inc.
|
|
|
|
Date: May 8, 2007 |
By: |
/s/ Michael
R. Cox |
|
Michael
R. Cox
Vice
President, Finance and Chief Financial Officer
|
Exhibit
Index
Exhibit
No. Description
99.1
|
Bioanalytical
Systems, Inc. press release, issued May 8,
2007.
|